EMEA (Europe, Middle East and Africa) Therapeutic Nuclear Medicines Market Report 2017

Choose Licence

 

In this report, the EMEA Therapeutic Nuclear Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. EMEA Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume (MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including Cardinal Health Mallkrodt Plc GE Healthcare Lantheus Medical Imaging Bayer AG Bracco Imaging SpA Eczacibasi-Monrol Nuclear Products Nordion Advanced Accelerator Applications SA IBA Molecular Imaging On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into Beta Emitters Therapeutic Nuclear Medicines Alpha Emitters Therapeutic Nuclear Medicines Brachytherapy Therapeutic Nuclear Medicines On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Therapeutic Nuclear Medicines for each application, including Hospitals Ambulatory Surgical Centers Other

 

Table of Contents EMEA (Europe, Middle East and Africa) Therapeutic Nuclear Medicines Market Report 2017 1 Therapeutic Nuclear Medicines Overview 1.1 Product Overview and Scope of Therapeutic Nuclear Medicines 1.2 Classification of Therapeutic Nuclear Medicines 1.2.1 EMEA Therapeutic Nuclear Medicines Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 EMEA Therapeutic Nuclear Medicines Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Beta Emitters Therapeutic Nuclear Medicines 1.2.4 Alpha Emitters Therapeutic Nuclear Medicines 1.2.5 Brachytherapy Therapeutic Nuclear Medicines 1.3 EMEA Therapeutic Nuclear Medicines Market by Application/End Users 1.3.1 EMEA Therapeutic Nuclear Medicines Sales (Volume) and Market Share Comparison by Application (2012-2022 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Other 1.4 EMEA Therapeutic Nuclear Medicines Market by Region 1.4.1 EMEA Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2012-2022) 1.4.2 Europe Status and Prospect (2012-2022) 1.4.3 Middle East Status and Prospect (2012-2022) 1.4.4 Africa Status and Prospect (2012-2022) 1.5 EMEA Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2012-2022) 1.5.1 EMEA Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2022) 1.5.2 EMEA Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2022) 2 EMEA Therapeutic Nuclear Medicines Competition by Manufacturers/Players/Suppliers, Region, Type and Application 2.1 EMEA Therapeutic Nuclear Medicines Market Competition by Players/Manufacturers 2.1.1 EMEA Therapeutic Nuclear Medicines Sales Volume and Market Share of Major Players (2012-2017) 2.1.2 EMEA Therapeutic Nuclear Medicines Revenue and Share by Players (2012-2017) 2.1.3 EMEA Therapeutic Nuclear Medicines Sale Price by Players (2012-2017) 2.2 EMEA Therapeutic Nuclear Medicines (Volume and Value) by Type/Product Category 2.2.1 EMEA Therapeutic Nuclear Medicines Sales and Market Share by Type (2012-2017) 2.2.2 EMEA Therapeutic Nuclear Medicines Revenue and Market Share by Type (2012-2017) 2.2.3 EMEA Therapeutic Nuclear Medicines Sale Price by Type (2012-2017) 2.3 EMEA Therapeutic Nuclear Medicines (Volume) by Application 2.4 EMEA Therapeutic Nuclear Medicines (Volume and Value) by Region 2.4.1 EMEA Therapeutic Nuclear Medicines Sales and Market Share by Region (2012-2017) 2.4.2 EMEA Therapeutic Nuclear Medicines Revenue and Market Share by Region (2012-2017) 2.4.3 EMEA Therapeutic Nuclear Medicines Sales Price by Region (2012-2017) 3 Europe Therapeutic Nuclear Medicines (Volume, Value and Sales Price), by Players, Countries, Type and Application 3.1 Europe Therapeutic Nuclear Medicines Sales and Value (2012-2017) 3.1.1 Europe Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017) 3.1.2 Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017) 3.2 Europe Therapeutic Nuclear Medicines Sales and Market Share by Type 3.3 Europe Therapeutic Nuclear Medicines Sales and Market Share by Application 3.4 Europe Therapeutic Nuclear Medicines Sales Volume and Value (Revenue) by Countries 3.4.1 Europe Therapeutic Nuclear Medicines Sales Volume by Countries (2012-2017) 3.4.2 Europe Therapeutic Nuclear Medicines Revenue by Countries (2012-2017) 3.4.3 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 3.4.4 France Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 3.4.5 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 3.4.6 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 3.4.7 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 3.4.8 Benelux Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 4 Middle East Therapeutic Nuclear Medicines (Volume, Value and Sales Price), by Region, Type and Application 4.1 Middle East Therapeutic Nuclear Medicines Sales and Value (2012-2017) 4.1.1 Middle East Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017) 4.1.2 Middle East Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017) 4.2 Middle East Therapeutic Nuclear Medicines Sales and Market Share by Type 4.3 Middle East Therapeutic Nuclear Medicines Sales and Market Share by Application 4.4 Middle East Therapeutic Nuclear Medicines Sales Volume and Value (Revenue) by Countries 4.4.1 Middle East Therapeutic Nuclear Medicines Sales Volume by Countries (2012-2017) 4.4.2 Middle East Therapeutic Nuclear Medicines Revenue by Countries (2012-2017) 4.4.3 Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 4.4.4 Israel Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 4.4.5 UAE Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 4.4.6 Iran Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 5 Africa Therapeutic Nuclear Medicines (Volume, Value and Sales Price) by Players, Countries, Type and Application 5.1 Africa Therapeutic Nuclear Medicines Sales and Value (2012-2017) 5.1.1 Africa Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2017) 5.1.2 Africa Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017) 5.2 Africa Therapeutic Nuclear Medicines Sales and Market Share by Type 5.3 Africa Therapeutic Nuclear Medicines Sales and Market Share by Application 5.4 Africa Therapeutic Nuclear Medicines Sales Volume and Value (Revenue) by Countries 5.4.1 Africa Therapeutic Nuclear Medicines Sales Volume by Countries (2012-2017) 5.4.2 Africa Therapeutic Nuclear Medicines Revenue by Countries (2012-2017) 5.4.3 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 5.4.4 Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 5.4.5 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 5.4.6 Algeria Therapeutic Nuclear Medicines Sales and Growth Rate (2012-2017) 6 EMEA Therapeutic Nuclear Medicines Manufacturers/Players Profiles and Sales Data 6.1 Cardinal Health 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Mallkrodt Plc 6.2.1 Company Basic Information, Manufacturing Base and Competitors 6.2.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Mallkrodt Plc Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 GE Healthcare 6.3.1 Company Basic Information, Manufacturing Base and Competitors 6.3.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Lantheus Medical Imaging 6.4.1 Company Basic Information, Manufacturing Base and Competitors 6.4.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Bayer AG 6.5.1 Company Basic Information, Manufacturing Base and Competitors 6.5.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Bayer AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Bracco Imaging SpA 6.6.1 Company Basic Information, Manufacturing Base and Competitors 6.6.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Bracco Imaging SpA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Eczacibasi-Monrol Nuclear Products 6.7.1 Company Basic Information, Manufacturing Base and Competitors 6.7.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Nordion 6.8.1 Company Basic Information, Manufacturing Base and Competitors 6.8.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Advanced Accelerator Applications SA 6.9.1 Company Basic Information, Manufacturing Base and Competitors 6.9.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 IBA Molecular Imaging 6.10.1 Company Basic Information, Manufacturing Base and Competitors 6.10.2 Therapeutic Nuclear Medicines Product Type, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 7 Therapeutic Nuclear Medicines Manufacturing Cost Analysis 7.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Therapeutic Nuclear Medicines Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 EMEA Therapeutic Nuclear Medicines Market Forecast (2017-2022) 11.1 EMEA Therapeutic Nuclear Medicines Sales, Revenue and Price Forecast (2017-2022) 11.1.1 EMEA Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2017-2022) 11.1.2 EMEA Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022) 11.1.3 EMEA Therapeutic Nuclear Medicines Price and Trend Forecast (2017-2022) 11.2 EMEA Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.3 Europe Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.4 Middle Eastt Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.5 Africa Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast by Region (2017-2022) 11.6 EMEA Therapeutic Nuclear Medicines Sales Forecast by Type (2017-2022) 11.7 EMEA Therapeutic Nuclear Medicines Sales Forecast by Application (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Therapeutic Nuclear Medicines Figure EMEA Therapeutic Nuclear Medicines Sales Volume (MT) by Type (2012-2022) Figure EMEA Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2016 Figure Beta Emitters Therapeutic Nuclear Medicines Product Picture Figure Alpha Emitters Therapeutic Nuclear Medicines Product Picture Figure Brachytherapy Therapeutic Nuclear Medicines Product Picture Figure EMEA Therapeutic Nuclear Medicines Sales Volume (MT) by Application (2012-2022) Figure EMEA Sales Market Share of Therapeutic Nuclear Medicines by Application in 2016 Figure Hospitals Examples Figure Ambulatory Surgical Centers Examples Figure Other Examples Figure EMEA Therapeutic Nuclear Medicines Market Size (Million USD) by Region (2012-2022) Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022) Figure Europe Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022) Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022) Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) Status and Forecast by Countries Figure EMEA Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2012-2022) Figure EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2022) Figure EMEA Therapeutic Nuclear Medicines Market Major Players Product Sales Volume (MT) (2012-2017) Table EMEA Therapeutic Nuclear Medicines Sales Volume (MT) of Major Players (2012-2017) Table EMEA Therapeutic Nuclear Medicines Sales Share by Players (2012-2017) Figure 2016 Therapeutic Nuclear Medicines Sales Share by Players Figure 2017 Therapeutic Nuclear Medicines Sales Share by Players Figure EMEA Therapeutic Nuclear Medicines Market Major Players Product Revenue (Million USD) (2012-2017) Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) by Players (2012-2017) Table EMEA Therapeutic Nuclear Medicines Revenue Share by Players (2012-2017) Table 2016 EMEA Therapeutic Nuclear Medicines Revenue Share by Players Table 2017 EMEA Therapeutic Nuclear Medicines Revenue Share by Players Table EMEA Therapeutic Nuclear Medicines Sale Price (USD/MT) by Players (2012-2017) Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Type (2012-2017) Table EMEA Therapeutic Nuclear Medicines Sales Share by Type (2012-2017) Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2012-2017) Figure EMEA Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017) Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2012-2017) Table EMEA Therapeutic Nuclear Medicines Revenue Share by Type (2012-2017) Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type in 2016 Table EMEA Therapeutic Nuclear Medicines Sale Price (USD/MT) by Type (2012-2017) Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Application (2012-2017) Table EMEA Therapeutic Nuclear Medicines Sales Share by Application (2012-2017) Figure Sales Market Share of Therapeutic Nuclear Medicines by Application (2012-2017) Figure EMEA Therapeutic Nuclear Medicines Sales Market Share by Application in 2016 Table EMEA Therapeutic Nuclear Medicines Sales (MT) and Market Share by Region (2012-2017) Table EMEA Therapeutic Nuclear Medicines Sales Share by Region (2012-2017) Figure Sales Market Share of Therapeutic Nuclear Medicines by Region (2012-2017) Figure EMEA Therapeutic Nuclear Medicines Sales Market Share in 2016 Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2012-2017) Table EMEA Therapeutic Nuclear Medicines Revenue Share by Region (2012-2017) Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2012-2017) Figure EMEA Therapeutic Nuclear Medicines Revenue Market Share Regions in 2016 Table EMEA Therapeutic Nuclear Medicines Sales Price (USD/MT) by Region (2012-2017) Figure Europe Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2012-2017) Table Europe Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017) Table Europe Therapeutic Nuclear Medicines Market Share by Type (2012-2017) Figure Europe Therapeutic Nuclear Medicines Market Share by Type in 2016 Table Europe Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017) Table Europe Therapeutic Nuclear Medicines Market Share by Application (2012-2017) Figure Europe Therapeutic Nuclear Medicines Market Share by Application in 2016 Table Europe Therapeutic Nuclear Medicines Sales (MT) by Countries (2012-2017) Table Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017) Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017) Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Countries in 2016 Table Europe Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017) Table Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017) Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017) Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016 Figure Germany Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure France Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure UK Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Russia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Italy Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Benelux Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Middle East Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Middle East Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017) Table Middle East Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017) Table Middle East Therapeutic Nuclear Medicines Market Share by Type (2012-2017) Figure Middle East Therapeutic Nuclear Medicines Market Share by Type (2012-2017) Table Middle East Therapeutic Nuclear Medicines Sales (MT) by Applications (2012-2017) Table Middle East Therapeutic Nuclear Medicines Market Share by Applications (2012-2017) Figure Middle East Therapeutic Nuclear Medicines Sales Market Share by Application in 2016 Table Middle East Therapeutic Nuclear Medicines Sales Volume (MT) by Countries (2012-2017) Table Middle East Therapeutic Nuclear Medicines Sales Volume Market Share by Countries (2012-2017) Figure Middle East Therapeutic Nuclear Medicines Sales Volume Market Share by Countries in 2016 Table Middle East Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017) Table Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017) Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017) Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016 Figure Saudi Arabia Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Israel Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure UAE Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Iran Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Africa Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Africa Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2012-2017) Table Africa Therapeutic Nuclear Medicines Sales (MT) by Type (2012-2017) Table Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017) Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Type (2012-2017) Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Type in 2016 Table Africa Therapeutic Nuclear Medicines Sales (MT) by Application (2012-2017) Table Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017) Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Application (2012-2017) Table Africa Therapeutic Nuclear Medicines Sales Volume (MT) by Countries (2012-2017) Table Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017) Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2012-2017) Figure Africa Therapeutic Nuclear Medicines Sales Market Share by Countries in 2016 Table Africa Therapeutic Nuclear Medicines Revenue (Million USD) by Countries (2012-2017) Table Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017) Figure Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2012-2017) Figure Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2016 Figure South Africa Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Nigeria Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Egypt Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Algeria Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Table Cardinal Health Therapeutic Nuclear Medicines Basic Information List Table Cardinal Health Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Cardinal Health Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Cardinal Health Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Mallkrodt Plc Therapeutic Nuclear Medicines Basic Information List Table Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Mallkrodt Plc Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Mallkrodt Plc Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table GE Healthcare Therapeutic Nuclear Medicines Basic Information List Table GE Healthcare Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure GE Healthcare Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure GE Healthcare Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Basic Information List Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Bayer AG Therapeutic Nuclear Medicines Basic Information List Table Bayer AG Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Bayer AG Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Bayer AG Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Bayer AG Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Bracco Imaging SpA Therapeutic Nuclear Medicines Basic Information List Table Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Bracco Imaging SpA Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Basic Information List Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Nordion Therapeutic Nuclear Medicines Basic Information List Table Nordion Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Nordion Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Nordion Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Basic Information List Table Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure Advanced Accelerator Applications SA Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table IBA Molecular Imaging Therapeutic Nuclear Medicines Basic Information List Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017) Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (MT) and Growth Rate (2012-2017) Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share in EMEA (2012-2017) Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share in EMEA (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines Figure Therapeutic Nuclear Medicines Industrial Chain Analysis Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2016 Table Major Buyers of Therapeutic Nuclear Medicines Table Distributors/Traders List Figure EMEA Therapeutic Nuclear Medicines Sales (MT) and Growth Rate Forecast (2017-2022) Figure EMEA Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2017-2022) Figure EMEA Therapeutic Nuclear Medicines Price (USD/MT) and Trend Forecast (2017-2022) Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Region (2017-2022) Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Region (2017-2022) Table EMEA Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Region (2017-2022) Figure EMEA Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region (2017-2022) Table Europe Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022) Figure Europe Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022) Table Europe Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022) Figure Europe Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022) Table Middle East Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022) Figure Middle East Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022) Table Middle East Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022) Figure Middle East Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022) Table Africa Therapeutic Nuclear Medicines Sales (MT) Forecast by Countries (2017-2022) Figure Africa Therapeutic Nuclear Medicines Sales Market Share Forecast by Countries (2017-2022) Table Africa Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Countries (2017-2022) Figure Africa Therapeutic Nuclear Medicines Revenue Market Share Forecast by Countries (2017-2022) Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Type (2017-2022) Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2017-2022) Table EMEA Therapeutic Nuclear Medicines Sales (MT) Forecast by Application (2017-2022) Figure EMEA Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2017-2022) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Other Reports by QY Research

Global Water-Hammer Arrestor Market Professional Survey Report 2017

This report studies Water-Hammer Arrestor in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 202...

Global Viral Molecular Diagnostics Market Professional Survey Report 2017

This report studies Viral Molecular Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast ...

Global Ultraviolet Tanning Bed Market Professional Survey Report 2017

This report studies Ultraviolet Tanning Bed in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2...

Global True Redox Flow Battery Market Professional Survey Report 2017

This report studies True Redox Flow Battery in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2...

Global The Fifth Generation Building Membrane Market Professional Survey Report 2017

This report studies The Fifth Generation Building Membrane in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, an...

New Pharmaceuticals and Healthcare Reports